Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: TCMD

Tactile Systems Technology, Inc.

Healthcare | Medical - Devices
$27.59 as of 2026-09-04 23:46 UTC
Market Cap$620M
Volume12.5K
EPS (TTM)$0.82

Tactile Systems Technology, Inc. (NASDAQ: TCMD) is a $620M medical - devices company trading at $27.59 — 33.6× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-09-04 23:46 UTC.

What Tactile Systems Technology, Inc. does

Tactile Medical is a medical device company that develops at-home treatment solutions for chronic diseases including lymphedema, chronic venous insufficiency, and chronic respiratory conditions. The company operates through two main business models: a direct-to-patient and -provider approach for lymphedema products, and a durable medical equipment distribution model for its respiratory therapy product, AffloVest. The company's lymphedema portfolio includes the Flexitouch Plus, Entre Plus, and Nimbl systems, all of which have received FDA clearance for treating various lymphedema conditions.

Summarized from Tactile Systems Technology, Inc.’s SEC filings · Read the filing ↗

Key facts

Quote
Price$27.59
Market cap$620M
Volume12.5K shares
Valuation
P/E (TTM)33.65×
EV/EBITDA14.90×
EPS (TTM)$0.82
Price/book2.83×
Return on equity8.72%

Revenue, margins & earnings

FY2021: net loss $12M on revenue $208M$208MFY2021FY2022: net loss $18M on revenue $247M$247MFY2022FY2023 Revenue: $274M — margin split not shown (non-operating gains)$274MFY2023FY2024 Net income: $17MFY2024 Taxes & interest: $5MFY2024 Operating expenses: $195MFY2024 Cost of revenue: $76M$293MFY2024FY2025 Net income: $19MFY2025 Taxes & interest: $10MFY2025 Operating expenses: $221MFY2025 Cost of revenue: $79M$330MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-12
  • 2026-08-12Dodd Sheri LouiseChief Executive OfficerSELL-10,978$323.2K
  • 2026-05-13Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERSELL-4,631$113.4K
  • 2026-05-08Asbury Valerie L.A6,521—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Tactile Systems Technology, Inc. do?

Tactile Medical is a medical device company that develops at-home treatment solutions for chronic diseases including lymphedema, chronic venous insufficiency, and chronic respiratory conditions.

What is TCMD's valuation?

TCMD trades at $27.59, 33.65× trailing earnings, 14.90× EV/EBITDA, as of 2026-09-04.

When did TCMD last file with the SEC?

Tactile Systems Technology, Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-13. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-09-04 23:46 UTC. This page is also available as JSON at /api/data?ticker=TCMD and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for TCMD and 5,000+ tickers.

Create a free account — keep TCMD
For your agent
GET /api/data?ticker=TCMD

This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt